Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Delic Holdings Corp (OP: DELCF )

0.0130 +0.0064 (+96.97%)
Streaming Delayed Price Updated: 2:36 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Delic Holdings Corp

< Previous 1 2 Next >
Rolling The Perfect Joint For A Quick & Efficient High, Researchers Say It Doesn't Involve Strong Weed
If you want to get very high quickly, according to a freelance science writer sharing her knowledge in the oldest continuously published magazine in the United States, you might assume smoking the... 
Via Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
Today's article highlights the performance of the munKNEE Psychedelic Drug Stocks Index which tracks the six (6) largest psychedelic stocks researching the treatment of mental illnesses based on the... 
Via Talk Markets
Delic Teams Up With Biotech Co. GT Research
Psychedelics wellness platform Delic Holding Corp Inc. (CSE: 
Via Benzinga
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
Psychedelic Drug Stocks Index Has A Good Week
We track six psychedelic stocks researching the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances. 
Via Talk Markets
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
October Recap: Major Psychedelic Drug Stocks Declined 9.9%
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD. 
Via Talk Markets
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada.  
Via Benzinga
Delic Completes Offering Of Debentures
Delic Holdings Corp (OTCQB: DELCF) (CSE:DELC) (FRA: 6X0) completed the sale of 1,240 units at a price of $1,000 per unit for aggregate gross proceeds of $1.24 million, on July 27, 2022. 
Via Benzinga
Strategic Cannabis Execs Making Changes At Companies You Know: Curaleaf, Valens, Copperstate & Delic
As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes... 
Via Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
Delic Holdings Corp. (OTCQB: DELCF) owns and operates an umbrella of psychedelics-related businesses towards improving access to health benefits across the U.S., including one of the largest chain of... 
Via Benzinga
Nation's Largest Ketamine Therapy Provider Offers Patient Resource For Holistic Mental Health Treatments
Through subsidiary Ketamine Wellness Centers (KWC), Delic Holdings Corp (OTCQB: DELCF) has launched the Ketamine Wellness Integrative Therapist Directory. 
Via Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics. 
Via Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
Delic Holdings Provides Default Status Update
Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) provided a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease... 
Via Benzinga
Veterans In Arizona Will Have Access To Ketamine Therapy At No Out-Of-Pocket Cost
Delic Holdings Corp’s (OTCQB: DELCF) Ketamine Wellness Center will provide military veterans in Arizona with ketamine therapy for treatment-resistant depression (TRD) and PTSD. 
Via Benzinga
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs
Psychedelics policy action took center stage this week. 
Via Benzinga
What Is NAD+, Ketamine Wellness Center's New Therapy?
Delic Holdings Corp.’s (OTCQB: DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy. 
Via Benzinga
Red White & Bloom, Delic And Chalice To Delay Filing Earnings Reports
It seems cannabis companies have joined the ongoing trend of filing their financial statements late. As reported new additions to the club are Delic Holdings and Chalice Brands, while Red White & Bloom... 
Via Benzinga
SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Delic Labs Receives Exemption To Conduct Research On MDMA, LSD And Other Psychedelic Compounds
Via Benzinga
Ketamine Wellness Centers Offering FDA Approved Esketamine Treatment For Major Depressive Disorder
Ketamine Wellness Centers subsidiary of Delic Holdings Corp (OTCQB: DELCF) (CSE:DELC) (FRA:6X0), has expanded its treatment options to include SPRAVATO nasal spray. The KWC clinics located in Houston,... 
Via Benzinga
Ketamine Wellness Centers Openes Mental Health Clinic In Reno Nevada
Ketamine Wellness Centers, the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp (CSE:DELC) ... 
Via Benzinga
Cannabis Dispensary Roundup: Delic Holdings, Ayr Wellness, High Tide
Delic Holdings Announces Grand Opening Of Salt Lake City Clinic Delic Holdings Corp (CSE: 
Via Benzinga
Delic Introduces Industry's First Family Support & Education Program At Ketamine Wellness Centers
On Thursday, Delic Holdings Corp (CSE:DELC) (OTCQB:... 
Via Benzinga
Delic Closes $10M Merger With Chain Of Ketamine Clinics
Psychedelic wellness company Delic Holdings Corp. (CSE:DELC) ... 
Via Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
The Week In Psychedelics: 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.